Ages2Come
Menu
View all results →
Categories
⚡ Breaking
Incumbent Sen. Ed Markey wins Massachusetts' Democratic primary for US Senate Apple Maps changes Lake Ontario to Lake America after Trump order Larry Page’s flying car company Pivotal loses its CEO Bill Simmons’s Co-Hosts Are Tired of His A.I. Antics SEC proposes transfer agent rule, sets event to figure out round-the-clock U.S. trading China dissented from G20 statement opposing 'cheap exports' flooding market, Bessent says Tim Cook to be paid $47mn as Apple’s executive chair Are all TVs at risk from burn-in? Here's how to avoid the problem altogether At G20 Meeting, Scott Bessent Accuses China of Flooding the World With Cheap Exports Will self-flying planes transform the skies? Incumbent Sen. Ed Markey wins Massachusetts' Democratic primary for US Senate Apple Maps changes Lake Ontario to Lake America after Trump order Larry Page’s flying car company Pivotal loses its CEO Bill Simmons’s Co-Hosts Are Tired of His A.I. Antics SEC proposes transfer agent rule, sets event to figure out round-the-clock U.S. trading China dissented from G20 statement opposing 'cheap exports' flooding market, Bessent says Tim Cook to be paid $47mn as Apple’s executive chair Are all TVs at risk from burn-in? Here's how to avoid the problem altogether At G20 Meeting, Scott Bessent Accuses China of Flooding the World With Cheap Exports Will self-flying planes transform the skies?
Health / Mobile

Eli Lilly says it will file for approval of next-generation obesity drug in 2027 as it clears two more trials

Source: cnbc July 23, 2026 · 03:45
There are now positive results from five late-stage trials on retatrutide, which Lilly is positioning as the next pillar of its obesity portfolio.
Read original article ← Back to Mobile

The original article opens on the publisher's website.

More from Mobile

View topic →